Skip to content
Clinical Trials – home
Region Oestergoetland
Sponsor

Region Oestergoetland

Sweden Universitetssjukhuset 1, 581 85 Linkoping, Sweden

About the sponsor

Clinical research includes acute kidney injury after coronary artery bypass surgery, hemodialysis care, and renal and ureteral malignancies, as well as benign renal tumours, nephrolithiasis, and renal reflux. Surgical and perioperative studies also address recovery in upper urinary tract surgery and fluid management in laparoscopic surgery.

  • Acute kidney injury
  • Hemodialysis
  • Upper urinary tract surgery
  • Renal and ureteral disease

Research activity spans both operative and supportive care settings, with attention to kidney protection, urinary tract surgery, and treatment-related outcomes in renal disease.

About Specializations

Region Oestergoetland runs clinical trials in conditions such as Medical device site joint infection, Laparoscopic surgery, Glomerulonephritis chronic, Ureteric cancer, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

9 clinical trials

Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Saline
  • Sponsor:Region Oestergoetland
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Human Albumin Solution
  • Sponsor:Region Oestergoetland
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Rituximab
  • Sponsor:Region Oestergoetland
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Anhydrous Lidocaine Hydrochloride
  • Sponsor:Region Oestergoetland
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Cloxacillin
  • Sponsor:Region Oestergoetland

Ovarian cancer+2

Recruiting
Registered drug
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Tinzaparin Sodium
  • Sponsor:Region Oestergoetland
Countries:SwedenSweden
  • Participants:0–17 years · 18–64 years
  • Substances:Lebrikizumab
  • Sponsor:Region Oestergoetland
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:L-Glutamic Acid
  • Sponsor:Region Oestergoetland
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Pyrazinamide
  • Sponsor:Region Oestergoetland

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).